[Featured Stock] Medicox Signs Exclusive Sales Contract for Diagnostic Kit Products... Surges Over 13%

[Asia Economy Reporter Park Jihwan] Medicox is showing strong performance following the news that it has signed an exclusive distribution agreement to sell and distribute diagnostic kit products from Flexense, a company specializing in diagnostic kit research and development, throughout South Korea and all of Europe.

As of 9:58 AM on the 11th, Medicox is trading at 1,615 KRW, up 13.68% (195 KRW).

Flexense is a company that developed COVID-19 serological antibody diagnostic kits, saliva antigen diagnostic kits, and serological neutralizing antibody diagnostic kits by receiving technology transfers for COVID-19 antigen and neutralizing antibodies from the Korea Research Institute of Bioscience and Biotechnology and the Osong Advanced Medical Industry Promotion Foundation under the Ministry of Health and Welfare, respectively.